Evidence map›Paper›PMID 29985393›Full record

ArticleNature communications2018

TCR signal strength controls thymic differentiation of iNKT cell subsets.

Kathryn D Tuttle, S Harsha Krovi, Jingjing Zhang, Romain Bedel, Laura Harmacek, Lisa K Peterson, Leonard L Dragone, Adam Lefferts, Catherine Halluszczak, Kent Riemondy and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 102 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. MAIT cells: Conserved watchers on the wall.The Journal of experimental medicine · 2025
    Review
  11. Review
  12. Article
  13. Article
  14. Innate-like T cell subset commitment in the murine thymus is independent of TCR characteristics and occurs during proliferation.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Kathryn D TuttleDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, 12800 E. 19th Ave, Aurora, CO, 80045, USA.ORCID http://orcid.org/0000-0002-9285-5297
S Harsha KroviDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, 12800 E. 19th Ave, Aurora, CO, 80045, USA.
Jingjing ZhangDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, 12800 E. 19th Ave, Aurora, CO, 80045, USA.
Romain BedelDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, 12800 E. 19th Ave, Aurora, CO, 80045, USA.
Laura HarmacekCenter for Genes, Environment, and Health, Department of Biomedical Research, National Jewish Health, 1400 Jackson Street, Denver, CO, 80206, USA.
Lisa K PetersonDepartment of Pediatrics, National Jewish Health, 1400 Jackson Street, Denver, 80206, CO, USA.
Leonard L DragoneDepartment of Pediatrics, National Jewish Health, 1400 Jackson Street, Denver, 80206, CO, USA.ORCID http://orcid.org/0000-0002-5198-0585
Adam LeffertsDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, 12800 E. 19th Ave, Aurora, CO, 80045, USA.
Catherine HalluszczakDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, 12800 E. 19th Ave, Aurora, CO, 80045, USA.
Kent RiemondyRNA Bioscience Initiative, University of Colorado School of Medicine, 12800 E. 19th Ave, Aurora, 80045, CO, USA.ORCID http://orcid.org/0000-0003-0750-1273
Jay R HesselberthRNA Bioscience Initiative, University of Colorado School of Medicine, 12800 E. 19th Ave, Aurora, 80045, CO, USA.
Anjana RaoLa Jolla Institute, 9420 Athena Cir, La Jolla, 92037, CA, USA.
Brian P O'ConnorCenter for Genes, Environment, and Health, Department of Biomedical Research, National Jewish Health, 1400 Jackson Street, Denver, CO, 80206, USA.
Philippa MarrackDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, 12800 E. 19th Ave, Aurora, CO, 80045, USA.
James Scott-BrowneLa Jolla Institute, 9420 Athena Cir, La Jolla, 92037, CA, USA.
Laurent GapinDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, 12800 E. 19th Ave, Aurora, CO, 80045, USA. Laurent.Gapin@ucdenver.edu.ORCID http://orcid.org/0000-0001-9730-5174
National Jewish Health · USLa Jolla Institute for Immunology · USUniversity of Colorado Denver · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USUniversity of Utah · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
TRAINING PROGRAM IN IMMUNOLOGYT32AI007405 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Laurel L Lenz, Raul Martin Torres · 1991 to 2026
$10.5M
NFAT, bZIP proteins, and transcriptional programs in lymphocytesR01AI109842 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Patrick Hogan, Anjana Rao · 2014 to 2026
$8.6M
CHARACTERISTICS OF T CELL RECEPTORSR01AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1985 to 2022
$7.3M
Nanopore analysis of transfer RNA forms and functionsR35GM119550 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI Jay R Hesselberth · 2016 to 2026
$4.5M
TCR signal strength and iNKT cell subset developmentR01AI130198 · NIAID · UNIVERSITY OF COLORADO DENVER · PI GAPIN, LAURENT · 2018 to 2022
$1.9M
CHARACTERISTICS OF T-CELL RECEPTORSR37AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1992 to 2001
$522k
The Effects of MHCI Heterozygosity on T Cell Receptor RepertoiresR21AI135374 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 2018 to 2019
$458k
Regulation of Natural Killer T cell lineage diversification by the Src-like Adaptor protein 2R21AI124076 · NIAID · UNIVERSITY OF COLORADO DENVER · PI GAPIN, LAURENT · 2016 to 2017
$422k
Inherent reactivity of T cell antigen receptors for MHC moleculesR21AI121761 · NIAID · UNIVERSITY OF COLORADO DENVER · PI GAPIN, LAURENT · 2016 to 2017
$421k
Characteristics of T Cell ReceptorsR56AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 2012 to 2012
$410k
NCI NIH HHS P30 CA046934NIAID NIH HHS R01 AI018785NIAID NIH HHS R01 AI109842NIAID NIH HHS R01 AI130198NIAID NIH HHS R21 AI121761NIAID NIH HHS R21 AI124076NIAID NIH HHS R21 AI135374NIAID NIH HHS R37 AI018785NIAID NIH HHS R56 AI018785NIAID NIH HHS T32 AI007405NIGMS NIH HHS R35 GM119550U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI121761U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI124076
6 · The paper itself

Abstract

During development in the thymus, invariant natural killer T (iNKT) cells commit to one of three major functionally different subsets, iNKT1, iNKT2, and iNKT17. Here, we show that T cell antigen receptor (TCR) signal strength governs the development of iNKT cell subsets, with strong signaling promoting iNKT2 and iNKT17 development. Altering TCR diversity or signaling diminishes iNKT2 and iNKT17 cell subset development in a cell-intrinsic manner. Decreased TCR signaling affects the persistence of Egr2 expression and the upregulation of PLZF. By genome-wide comparison of chromatin accessibility, we identify a subset of iNKT2-specific regulatory elements containing NFAT and Egr binding motifs that is less accessible in iNKT2 cells that develop from reduced TCR signaling. These data suggest that variable TCR signaling modulates regulatory element activity at NFAT and Egr binding sites exerting a determinative influence on the dynamics of gene enhancer accessibility and the developmental fate of iNKT cells.

Indexed as

AnimalsBinding SitesCell DifferentiationCells, CulturedEarly Growth Response Protein 2Gene Expression ProfilingMice, Inbred BALB CMice, Inbred C57BLMice, TransgenicNatural Killer T-CellsNFATC Transcription FactorsReceptors, Antigen, T-CellSignal TransductionThymocytesT-Lymphocyte SubsetsEarly Growth Response Protein 2Egr2 protein, mouseNFATC Transcription FactorsReceptors, Antigen, T-Cell

Identifiers

PMID29985393
PMCPMC6037704
OpenAlexW2810644465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.